Study identifies candidates for therapeutic targets in pediatric germ cell tumors
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide the development of more personalized therapies for pediatric germ cell tumors (GCTs). Although GCTs account for only 3% of childhood cancers, they challenge doctors and researchers due to their diversity and the toxicity of available treatments.
The main approach today involves surgery combined with chemotherapy. ...